SYNCAR-100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SYNCAR-100, covering 2026-02-24 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia [EARLY_Phase 1]